According to the research analysis, the global cell sorting market size was valued at USD 216.2 Million in 2020 and estimated to be growing at a CAGR of 7.07% to reach USD 304.2 Million by 2025 the forecast period.
Cell sorting is an essential tool, which is broadly used in many components of biomedical, biological research, and clinical therapy. Cell sorting is used to separate specific cells from the heterogeneous cell mixture. Cell sorting reagent allows the isolation of any cell from any species.
Flow cytometers assist these systems in separating varied types of cells based on their properties. Fluorescence-Activated Cell Sorting (FACS) and cell imaging microscopes are the methods used by this system to characterize the various particles or cells. Cell-sorting system helps in rare cells precise isolation from a sample of heterogeneous cells, thereby enabling the downstream study of cells for varied applications. Cell-sorting system has several applications from malignancy genomics, basic research, clinical trials to forensic and non-invasive prenatal diagnosis.
MARKET DRIVERS
Factors responsible for the driving of growth of the market are rising funding and investments for the development of technologically advanced cell sorters, technological advancements in cell sorters, and growing adoption of cell sorting techniques in research activities. The Global Cell Sorting Market is also driven by factors like increasing pharmaceutical and biotechnology industries, the launch of specific reagents for specific applications, and the rising prevalence of HIV/AIDS and cancer.
Fast-growing markets, including Asia-Pacific and Latin America, the emergence of microfluidics technology for cell-sorting and continuous growth in the research of stem cells are expected to offer new opportunities for the organizations operating in the global cell sorting market.
Across Asia-Pacific, countries like India and China, with emerging economies, are increasingly becoming a preferred destination for companies in cell sorting due to the rise in common diseases like cancer. Funds are being poured into the latest research and development activities. Asia-Pacific is also experiencing high commonness in chronic diseases such as HIV and other applicable disorders that produce plenty of opportunities for the global cell sorting market growth.
MARKET RESTRAINTS
However, factors such as the high cost of equipment and lack of awareness & technical knowledge regarding cell sorters are hindering the growth of the global cell sorting market.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Technology, Product, Application, End-User and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the global cell sorting market has been segmented and sub-segmented based on the technology, product, application, end-user, and region.
Cell Sorting Market - By Technology:
Based on the technology, the Fluorescence-based Droplet Cell Sorting segment is estimated to account for leading shares in the market during the forecast period. FACS offers fast, objective, and quantitative recording accuracy and full applications, which surge the segment growth globally.
The microfluidics segment is projected to showcase the fastest CAGR due to new products invention, which produces high demand in this Technology.
Cell Sorting Market - By Product:
Based on the product, the cell sorters segment is expected to dominate the cell sorting market due to advanced technologies. The invention of new instruments has made the sorting procedure, which leads to quick results.
The reagents and consumables segment holds a considerable share in the cell sorting market.
Cell Sorting Market - By Application:
Based on the application, the research segment is expected to grow at a promising CAGR due to increasing cancer research. The clinical application segment is anticipated to have a lucrative growth rate as a frequent increase in diseases like HIV and cancer.
Cell Sorting Market - By End-User:
Based on the end-user, the research institutes segment accounts for the largest share in the cell sorting market throughout the forecast period. The segment is driven by the growing number of research activities in cellular analysis, an increasing number of cell-based therapies and applications, and also growing investments and funds in cancer and stem cell research propel the segment growth globally.
Medical schools are estimated to have considerable growth in the cell sorting market due to increasing collaborations, mergers, and acquisitions between pharma and biotech companies, which leads to growth in several research activities.
Cell Sorting Market - By Region:
Regionally, North America is estimated to have the largest share in the global cell sorting market, followed by Europe and Asia-Pacific.
North America is projected to have dominating shares in the global market during the forecast period. Huge investments made in pharmaceutical and biotechnology companies and growing obtainment of cell sorting towards cancer research is fuelling the market growth. The U.S. is leading this region due to the growing occurrence rate of cancer, which drives this region's growth. Nearly 133 million Americans, which means more than 40% of the population, are affected by chronic diseases.
The European cell sorting market was the second largest region followed by North America in the global market in 2019 due to upgraded research infrastructures, significant expenditure spent on healthcare, and increasing funds for research from government and other organizations.
The Asia-Pacific market is projected to have the highest growth potential by 2025. Emerging markets in developing countries like India and China have become attractive places to the companies for the development and marketing of cell sorters. Factors contributing to the growth of the Asia-Pacific cell sorting technologies market include an increase in funding for cancer research activities and increasing support from the government to reinforce the biotechnology industry.
Latin America region is contributed by growing demand for cell therapies, high capability of stem cells and growth in cancer research and advancements in technology, and an increase in chronic diseases in the cell sorting market during the analysis period. Brazil is one of the largest leading countries in this region, followed by Mexico, Argentina, and Columbia.
The Middle East & Africa region is anticipated to have the least and slow growth rate in the cell sorting market of this region.
TOP COMPANIES IN THE MARKET
List of key market participants leading the global cell sorting market covered in this report are Becton, Dickinson, and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Affymetrix Inc. (U.S.), Sony Biotechnology, Inc. (U.S.), Sysmex Partec GmbH (Japan), Cytonome/ST, LLC (U.S.), On-Chip Biotechnologies Co., Ltd. (Japan), and Union Biometrica, Inc. (U.S.)
KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
On April 03, 2019, Miltenyi Biotec has introduced a new platform for fully automated and high content imaging at the AACR ANNUAL MEETING 2019 in ATLANTA, the MACSima Imaging Platform.
June 04, 2019, Beckman Coulter Life Sciences, has announced that its acquisition with Cytobank, which provides a software platform for multi-parametric single-cell data analysis, software as a service company based in Santa Clara, California.
On March 11, 2019, the reconstruction of kidney tubules derived from human kidney adult stem cells in microfluidic chips. The tubules show cilia at the luminal side and ion transporters at the blood side.
On January 23, 2019, STEMCELL Technologies had launched mTeSR Plus, an enhanced version of mTeSR 1, widely accepted feeder-free human pluripotent stem cell maintenance medium. It has undergone beta testing with several members of the Stem Cell Coredinates group.
On March 05, 2018, Terumo BCT, a U.S. based global leader in blood component and cellular technologies, has selected services and consulting firm Capgemini to set up two global innovation and development (I&D) centers in India.
On October 11, 2018, UniCAR- Therapy Bio-Medicine technology chose Terumo BCT and its cell expansion devices to implement automation in its cell therapy manufacturing process for chimeric antigen receptor CAR T-cell therapies.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Technology
5.1.1 Introduction
5.1.2 FACS
5.1.3 MACS
5.1.4 Microfluids
5.1.5 Y-o-Y Growth Analysis, By Technology
5.1.6 Market Attractiveness Analysis, By Technology
5.1.7 Market Share Analysis, By Technology
5.2 Product
5.2.1 Introduction
5.2.2 Cell Sorters
5.2.3 Reagents
5.2.4 Consumables
5.2.5 Y-o-Y Growth Analysis, By Product
5.2.6 Market Attractiveness Analysis, By Product
5.2.7 Market Share Analysis, By Product
5.3 Application
5.3.1 Introduction
5.3.2 Research
5.3.3 Clinical
5.3.4 Y-o-Y Growth Analysis, By Application
5.3.5 Market Attractiveness Analysis, By Application
5.3.6 Market Share Analysis, By Application
5.4 End user
5.4.1 Introduction
5.4.2 Research Institutes
5.4.3 Biopharma Companies
5.4.4 Medical Schools
5.4.5 Y-o-Y Growth Analysis, By End user
5.4.6 Market Attractiveness Analysis, By End user
5.4.7 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Technology
6.1.3.3 By Product
6.1.3.4 By Application
6.1.3.5 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Technology
6.1.4.3 By Product
6.1.4.4 By Application
6.1.4.5 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Technology
6.1.5.3 By Product
6.1.5.4 By Application
6.1.5.5 By End user
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Becton, Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Bio-Rad Laboratories, Inc.
8.3 Beckman Coulter, Inc.
8.4 Miltenyi Biotec GmbH
8.5 Affymetrix Inc.
8.6 Sony Biotechnology, Inc.
8.7 Sysmex Partec GmbH
8.8 Cytonome/ST, LLC
8.9 On-Chip Biotechnologies Co., Ltd.
8.10 Union Biometrica, Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Feb 2020
Feb 2020
